Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
Published April 12, 2023 · Recall initiated: March 23, 2023
Summary
FDA records drug Class II recall D-0526-2023, published April 12, 2023 and initiated March 23, 2023. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 32 Bottles; Lot: Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What to do
Voluntary: Firm initiated · Letter
Get an email if TADALAFIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TADALAFIL
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDCMay 3, 2023
- FDATadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals,May 3, 2023
- FDASimvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDCApril 12, 2023
- FDAGlimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NCApril 12, 2023
- FDATadalafil Tablets, USP 10 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-371-10, UPC 3 16729 37110 0;March 8, 2023
- FDATadalafil Tablets, USP, 5 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-370-10, UPC 3 16729 37010 3;March 8, 2023
Questions about this recall
Was Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7 recalled?
Yes. FDA published recall D-0526-2023 on April 12, 2023. Reported hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TADALAFIL.